Avadel Pharmaceuticals-adr logo

Avadel Pharmaceuticals-adr Share Price AVDL

$21.67

▲

0.04

(0.18%)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 11 Feb 2026

Check the interactive Avadel Pharmaceuticals-adr Stock chart to analyse performance

Avadel Pharmaceuticals-adr Key Stats

Check Avadel Pharmaceuticals-adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$21.63
Open
$21.66
Market Capitalization
$2.1B
Today's Volume
$35.0M
Revenue TTM
$248.5M
EBITDA
$2.7M
Earnings Per Share (EPS)
$0.0
PE Ratio
0.0
Profit Margin
-0.11%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-0.32%

Global Institutional Holdings in Avadel Pharmaceuticals-adr

  • Name

    Holdings %

  • HHG PLC

    11.46%

  • BlackRock Inc

    7.01%

  • Brandes Investment Partners & Co

    6.68%

  • Two Seas Capital LP

    6.34%

  • Vanguard Group Inc

    5.73%

  • Gendell Jeffrey L

    5.33%

Analyst Recommendation on Avadel Pharmaceuticals-adr Stock

Rating
Trend

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Avadel Pharmaceuticals-adr(by analysts ranked 0 to 5 stars)

About Avadel Pharmaceuticals-adr

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland.
Organization
Avadel Pharmaceuticals-adr
Employees
188
CEO
Mr. Gregory J. Divis Jr.
Industry
Health Technology

Key Management of Avadel Pharmaceuticals-adr

NameTitle
Mr. Gregory J. Divis Jr.
CEO & Director
Mr. Thomas S. McHugh
Senior VP, Principal Financial & Accounting Officer and CFO
Mr. Jerad G. Seurer
General Counsel, Company Secretary & Compliance Officer
Ms. Susan Rodriguez
Chief Operating Officer
Mr. Gregory J. Davis
VP of Corporate and Business Development
Ms. Angie Woods
Vice President of People & Culture
Dr. Jason M. Vaughn Ph.D., R.Ph.
Senior Vice President of Technical Operations
Ms. Jennifer Gudeman PharmD
Senior Vice President of Medical & Clinical Affairs
Dr. Polly A. Murphy D.V.M., M.B.A., Ph.D.
Chief Business Officer
Ms. Marla Scarola M.S.
Senior Vice President of Regulatory & Quality

Important FAQs about investing in AVDL Stock from India :

What is Avadel Pharmaceuticals-adr share price today?

Avadel Pharmaceuticals-adr share price today is $21.67 as on at the close of the market. Avadel Pharmaceuticals-adr share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Avadel Pharmaceuticals-adr share?

Avadel Pharmaceuticals-adr share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Avadel Pharmaceuticals-adr stock price today i.e. is closed at $21.67, lower by 8.06% versus the 52 week high.

How to invest in Avadel Pharmaceuticals-adr Stock (AVDL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Avadel Pharmaceuticals-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avadel Pharmaceuticals-adr Shares that will get you 0.0692 shares as per Avadel Pharmaceuticals-adr share price of $21.67 per share as on February 11, 2026 at 12:00 am IST.

What is the minimum amount required to buy Avadel Pharmaceuticals-adr Stock (AVDL) from India?

Indian investors can start investing in Avadel Pharmaceuticals-adr (AVDL) shares with as little as ₹94.69 or $1 (as of June 23, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹946.90 in Avadel Pharmaceuticals-adr stock (as per the Rupee-Dollar exchange rate as on June 23, 2026). Based on Avadel Pharmaceuticals-adr share’s latest price of $21.67 as on February 11, 2026 at 12:00 am IST, you will get 0.4615 shares of Avadel Pharmaceuticals-adr. Learn more about fractional shares .

What are the returns that Avadel Pharmaceuticals-adr has given to Indian investors in the last 5 years?

Avadel Pharmaceuticals-adr stock has given 0.0% share price returns and 27.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?